David O’Reilly
David O’Reilly has over 25 years of experience as a consultant in the life sciences industry and in the founding, financing, scaling and partnering of innovative pharmaceutical and medical technology companies. He currently provides strategic advisory, product development and financing services to global life sciences companies, start-ups and investors.
He serves on the Board of Directors of Baymatob (a women-founded and led medical technology company focused on maternal and fetal health), Cavalon Therapeutics (a biotechnology company focused on drug/device combination products for Parkinson’s disease) and The Health Trust (a nonprofit operating foundation focused on health equity and access). He also serves on the Advisory Boards of HealthRhythms (a digital therapeutics company focused on mental health) and Paradromics (a medical technology company focused on Brain Computer Interface products).
David has co-founded and held executive roles at several successful life sciences companies, including Proteus Digital Health, Catalyst Biosciences, Iconix Biosciences, ARIAD Pharmaceuticals and L.E.K. Consulting. David is an inventor on over a dozen issued and pending patents related to digital technologies and their application to drug discovery, therapeutic products and health care monitoring. He earned an MBA from Harvard Business School, where he graduated with Distinction, and a BA from Wesleyan University, where he was named the Gilbert H. Clee Scholar.
Location: San Francisco, CA
